-
24/7 available services
-
Multiple myeloma, also known as myeloma, is a type of cancer that affects plasma cells, which are a crucial component of the immune system.
The exact cause of multiple myeloma is unknown. However, certain factors can increase the risk of developing this condition, including age (most commonly diagnosed in individuals over 65), male gender, a family history of myeloma or related conditions, exposure to radiation or certain chemicals, obesity, and certain genetic abnormalities.
In the early stages, multiple myeloma may not cause any noticeable symptoms. However, as the disease progresses, the following signs and symptoms may occur:
Bone pain: Myeloma cells can accumulate in the bone marrow, leading to bone pain, especially in the spine, hips, ribs, and skull.
Fatigue and weakness: The growth of myeloma cells can crowd out healthy blood cells, resulting in anemia, which can cause fatigue, weakness, and shortness of breath.
Frequent infections: Myeloma cells can suppress the immune system, making individuals more susceptible to infections (such as pneumonia, urinary tract infections, or sepsis).
Bone fractures: Weakened bones due to myeloma can be prone to fractures or breaks even after minor trauma.
Kidney problems: Myeloma cells can produce substances that impair kidney function, leading to symptoms such as increased thirst, frequent urination, and swelling in the legs.
Abnormal blood tests: Blood tests may reveal abnormal levels of certain proteins (such as monoclonal antibodies) and components of the blood, including calcium and red blood cells.
The treatment of multiple myeloma depends on several factors, including the stage of the disease, overall health, and individual considerations. Common treatment options may include:
Chemotherapy: Medications are used to kill myeloma cells or slow their growth.
Stem cell transplant: High-dose chemotherapy is followed by a transplant of healthy stem cells to help rebuild a healthier immune system.
Targeted therapies: Drugs specifically target and inhibit the growth of myeloma cells or the substances they produce.
Immunomodulatory drugs: These medications enhance the immune system's response to fight the myeloma cells.
Radiation therapy: High-energy X-rays or other types of radiation are used to kill cancer cells or minimize bone pain caused by myeloma.
Supportive care: Measures such as pain management, antibiotics to prevent or treat infections, and medications to manage side effects may be provided to improve quality of life.
While multiple myeloma is not typically considered a hereditary condition, there is a slightly increased risk for individuals with a family history of the disease. Genetic factors may play a role in determining susceptibility to multiple myeloma, but it is not solely a hereditary disease.
Yes, multiple myeloma can spread to other parts of the body. It often affects multiple bones and bone marrow, but it can also affect other organs such as the kidneys, liver, and lungs. Regular monitoring and appropriate treatment can help manage the spread of the disease.
While there is currently no known cure for multiple myeloma, significant advancements in treatment options have improved outcomes and prolonged survival. Treatment strategies focus on managing the disease, achieving remission, and controlling symptoms to enhance the quality of life for individuals with multiple myeloma.
Multiple myeloma can weaken the bones and increase the risk of fractures due to the accumulation of cancerous plasma cells in the bone marrow. These plasma cells produce substances that degrade bone tissue, leading to bone lesions, bone pain, and an increased risk of fractures.
The prognosis for multiple myeloma varies depending on various factors, such as the stage of the disease, overall health, and response to treatment. With advancements in treatment options, some individuals with multiple myeloma can achieve long-term remission and lead fulfilling lives. Regular follow-up care and adherence to the recommended treatment plan are essential for optimizing prognosis.